T 2113/17 of 07.03.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T211317.20230307
- Date of decision
- 7 March 2023
- Case number
- T 2113/17
- Petition for review of
- -
- Application number
- 08841705.0
- IPC class
- A61M 1/34
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- OPTIMIZING CLEARANCE FOR PROTEIN BOUND MOLECULES USING CASCADE FILTRATION THERAPY
- Applicant name
- Nikkiso Co., Ltd.
- Opponent name
- Fresenius Medical Care AG & Co. KGaA
- Board
- 3.2.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(3)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 84Rules of procedure of the Boards of Appeal 2020 Art 012(2)Rules of procedure of the Boards of Appeal 2020 Art 013(2)Rules of procedure of the Boards of Appeal 2020 Art 025(2)Rules of procedure of the Boards of Appeal Art 12(2)Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Primary object of appeal proceedings to review decision
Late-filed facts - submitted with the statement of grounds of appeal - admitted (no)
Amendment after summons - exceptional circumstances (no) - taken into account (no)
Amendments - broadening of claim (no)
Claims - clarity (yes)
Novelty - (yes)
Inventive step - (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.